The overall nutraceuticals market is growing at a higher rate than pharmaceuticals. However, the growth in the nutraceutical market does not entirely translate to excipients market growth for nutraceutical OSDFs. The reason: Excipients are mainly used in the nutraceutical oral solid forms of tablets and capsules and not in forms such as protein powders or other functional foods that are growing at a slightly higher rate. While the United States is the largest market, the European market will be growing more quickly, with some segments, such as functional coatings for nutraceuticals, still developing.
Here are the 10 biggest trends in excipients for the nutraceutical oral solid dosage forms market:
Note: Due to technical issues resulting from an overwhelming number of people working from home worldwide, our digital platform is having difficulties hosting events. To avoid unnecessary stress to attendees and with hopes that the platform will resolve their technical problems, we are postponing the live webinar to March 25, 2020.
Webinar Introduction: There have been a number of developments over the years in the biocide industry from regulatory clampdowns through to consolidations and divestments. This brief seminar aims to provide a high-level overview of Lonza’s specialty ingredients business in the context of the biocides and personal care markets.
The nutraceutical and, subsequently, excipients market for oral solid dosage forms (OSDFs) is both driven and challenged by consumer awareness. On one hand, rising healthcare costs and the growing consumer focus toward a healthy lifestyle, plus a proactive nutritional approach to avoid chronic diseases, drive the market. On the other hand, consumers are growing more conscious of the health and environmental consequences of products they consume, a trend that is driving the “clean label” movement. These and many other trends and challenges to nutraceutical oral solid dosages are analyzed in the just-published report Excipients for Nutraceutical Oral Solid Dosage Forms: Market Analysis and Opportunities. To learn reports key findings, REGISTER for our upcoming webinar.Continue reading
This webinar is based on Kline’s just-published report covering Industrial Surfactants: Global Market Analysis and Opportunities. It will help you gain a general understanding of industrial applications driven by complex, application-related drivers, whose identification is key for building a successful, targeted business strategy.
Biopharmaceuticals commonly called “biologics,” include a wide variety of products derived from human, animal, or microbial sources with the help of biotechnology. A surge of bio-APIs and their growing penetration into multiple therapies create an attractive market for pharmaceutical chemical suppliers.Continue reading
The overall professional janitorial and housekeeping market is growing slowly but steadily and, in general, tracks the slow increase in the U.S. population. Each end-user segment has its own growth dynamics based on how its number of guests, students, residents, patients, or visitors are changing. Continue reading
A surging number of biologic APIs and their growing penetration into multiple therapies create an attractive market segment for pharmaceutical ingredient suppliers but not one without challenges, analyzes Kline’s recently published Biologics: Market Opportunities for Chemicals Suppliers. To learn about key findings from the study, REGISTER for a complimentary webinar, taking place on October 17, 2019.
Currently, more than 350 biologics are commercially presented in the biopharmaceuticals market. Some established biologics, such as Humira and Avastin, maintained their growth of the last decade in 2018, with sales growing by 8.2% and 9.5%, respectively. New drugs such as Opdivo, which was first introduced in 2017, witnessed particularly robust growth in the overall biopharmaceutical market.Continue reading